Global Blood Therapeutics, a biopharmaceutical company focused on developing novel, orally-available therapeutics for chronic blood diseases, today announced that the company will present the first-ever data on its lead program in sickle cell disease (SCD) as an oral presentation and a poster session at the 55th American Society of Hematology (ASH) Annual Meeting and Exposition taking place December 7-10, 2013 in New Orleans.
Help employers find you! Check out all the jobs and post your resume.
